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Abstract
The use of blood pressure measurements have become a routine part of physical exam for the evacuation of
cardiovascular health adults and, more recently, children. The most widely used definition of hypertension is
delineate as greater than 90 % BP according to age, sex, and height by the National High Blood Pressure Education
Program. Current research suggests that pediatric hypertension is influenced by multitude of factors including birth
weight, maturity during birth, heredity, and diet leading to primary hypertension. Factors influencing secondary
hypertension include renal abnormalities, coarctation of the aorta, medications, neoplasm, etc. The treatment for
pediatric hypertension is carried out with diet and exercise as the first line of defense. Only under non-compliance
with diet and exercise is pharmaceutical intervention appropriate. This paper outlines a concise summary of the
current understanding and research for scientists, clinicians, as well as for the general population to better
understand pediatric hypertension.
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Background
Blood pressure measurements for adults have proven to
be crucial in the assessment of cardiovascular health,
and since Stephen Hales’ experiments in the eighteenth
century, have become a routine part of physical exam
[1]. However, it wasn’t until 1977 that proper assessment
of hypertension in children was carried out by the Task
Force on Blood Pressure Control in Children [2]. Since
then, numerous studies have been conducted to better
understand hypertension in children. We will layout a
concise summary of the current understanding and re-
search for scientists, clinicians, as well as for the general
population to better understand pediatric hypertension.
Definition and prevalence of hypertension in
children
In 2004, the National High Blood Pressure Education Pro-
gram published its fourth report on hypertension in chil-
dren with detailed definitions of pediatric hypertension
[3]. This definition utilizes specific age, sex, and height to
define the 50th, 90th, 95th, and 99th percentile blood
pressure (BP) data tables to determine normal BP. [3].
This report defines hypertension as over 90 % BP
according to age, sex, and height [3].
Using the most current definition of hypertension in chil-
dren, studies have found the prevalence to range between
4.7 and 19.4 % depending on a variety of factors such as
age, sex, ethnicity, body mass index (BMI), parental hyper-
tensive status, etc. [4, 5]. Hypertensive and pre-hypertensive
status closely followed BMI [4]. Prevalence of hypertension
was highest among Hispanics (25 %) and lowest among
Asians (14 %) [5]. The explosion of obesity among children,
5 to 11 % from 1960s to 1990s, has caused a dramatic in-
crease in hypertension among children [6]. Studies indicate
that more than 20 % of children that are obese have pri-
mary hypertension [7]. This trend of increased childhood
obesity will continue to have a dramatic impact on the car-
diovascular health of American children and is something
that clinicians must be aware off.
Factors influencing blood pressure in children
Blood Pressure varies widely during a child’s development
with an overall steadily increasing trend. The average sys-
tolic blood pressure at birth is approximately 70 mmHg
which increases to 85 mmHg by one month of age [8].
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Blood pressure in premature infants is considerably lower
and is directly related to the weight [9]. Previous research
has shown a significant inverse relationship between birth
weight and risk for hypertension later in life placing pre-
mature infants in the greater risk category [10]. Starting
during preschool age, children seem to be placed in a per-
centile distribution that they tend to follow throughout
their life giving weight to the theory that essential hyper-
tension begins in childhood [11].
As with adult hypertension, traditional separation of
primary and secondary classification is useful for chil-
dren. Children with secondary hypertension have a spe-
cific, potentially correctable, abnormality responsible for
their high blood pressure while those with primary or
essential hypertension do not.
Primary hypertension
Primary hypertension affects millions around the world.
Our inability to identify the cause of elevated blood pres-
sure in primary hypertension undoubtedly reflects both
the complex physiologic process that regulates blood pres-
sure and the heterogeneous nature of this disorder [12].
One of the most important factors influencing primary
hypertension in children is heredity [4, 9, 12, 13].
Children with paternal and/or maternal history of
hypertension demonstrated significant risk for devel-
oping primary hypertension before the age of 18 [4].
There is a greater influence of heredity from paternal
side than from maternal side [4]. However, other studies
have found the opposite to be true leaving no significant
consensus on this matter in the scientific community [9].
The inheritance pattern for hypertension seems to be
multifactorial and is modified by environmental fac-
tors [13].
Diet has also been linked to primary hypertension in
children. Multiple studies show a significantly higher
percent of hypertensive children with non-vegetarian
diet [4, 14]. Decades of research have also correlated high
sodium intake and high blood pressure [4, 9, 12, 13]. The
sensitivity of sodium on hypertension appears to be genet-
ically determined as well [13].
The relationship between obesity and hypertension in
children is well documented since the 80’s. Current stud-
ies indicate that overweight children and adolescents are
at a substantially increased risk for several Cardiovascular
Disease (CVD) risk factors. The association between obes-
ity and high systolic blood pressure (SBP) among 2 to
9 year old children appears to be stronger than in adoles-
cents [7]. The pathophysiology of obesity-associated
hypertension has not been clearly defined. Research
indicates that insulin resistance and hyperinsulinemia
might contribute to enhanced renal sodium reabsorp-
tion or increasing sympathetic nervous system activ-
ity [15].
Secondary hypertension
Secondary hypertension is accompanied with pathology
or medications that could be correlated to the hyper-
tension. Secondary hypertension is more common than
primary hypertension in infants and young children. In
fact, up to 85 % of children with hypertension have an
identifiable cause [16]. It is the recommendation that all
children with confirmed hypertension be evaluated for
underlying causes to include renal parenchymal disease
[16]. Table 1 cites common causes of secondary hyper-
tension in children [12, 13, 17].
The causes of hypertension vary with age. Renal artery
thrombosis or stenosis, congenital renal malformations,
or coarctation of aorta present with newborn hyperten-
sion [13]. While these conditions present with obvious
signs and symptoms, studies indicate a significant delay
in the diagnosis due to improper assessment of blood
pressure by physicians [12]. Children older than 6 years
of age, renal artery stenosis and renal parenchymal are
Table 1 Most common causes of secondary hypertension by age
Age group Etiology
Newborn – First year Renal artery or venous thrombosis
Renal artery stenosis
Congenital renal abnormalities






First to 6 years Renal parenchymal disease
Renovascular disease





Age 6 to 10 years Renal parenchymal disease
Essential hypertension
Renovascular disease
Coartctation of the aorta
Endocrine causes
Tumor




Coartctation of the aorta
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the leading definable causes of diastolic blood pressure
measurements in excess of 90 to 100 mmHg [12].
Approximately 75–80 % of children with secondary
hypertension have a renal abnormality [18]. In adoles-
cent females, oral contraceptives have been associated
with hypertension. The stimulation of renin-angiotension-
aldosterone system as well as other related patholo-
gies leading to secondary hypertension are listed in
Table 1 [19].
Ambulatory blood pressure monitoring
Traditionally, blood pressure measurements have been
taken while the patient was at the office, but these prac-
tices only demonstrate the pressure in a certain setting.
In children, these recorded blood pressures can be vastly
different from when the child is at home or during their
daily routines. Ambulatory blood pressure monitoring
(ABPM) can show blood pressures at various times
throughout the day and in various settings ([20].) Be-
cause ABPM can allow the clinician to get an accurate
pattern of blood pressure in the patient, ABPM can
be helpful in predicting target-organ damage, and
may be a more accurate blood pressure measurement
[20, 21]. In healthy children, ABPM has demonstrated
significantly improved daytime SBP and DBP, along
with a lower HR, as a result of a simple breathing
meditation intervention [21]. While multiple single-
center case series have demonstrated the usefulness
of ABPM in identifying persistently hypertensive
youths with normal clinic BP, large-scale pharmaco-
logic trials in children utilizing ABPM have not been
reported [21].
Hypertension and target-organ damage
Prolonged hypertension can impact many organs if left
unresolved. Organs and structures at risk are: heart, kid-
ney, vascular walls, and the nervous system [22]. Child-
hood and adolescent hypertension is linked to future
target-organ damage [21]. Target-Organ damage can in-
clude, but is not limited to carotid intima-media thick-
ness, left ventricular mass, arterial stiffness, and left
ventricle hypertrophy [21]. In children and adolescents
with hypertension, it is essential to assess target-organs
for any changes [22].
Symptoms
Children with hypertension rarely have clinical evidence
of the disease. The increased blood pressure is usually
detected during a normal examination or before a phys-
ical examination for sports participation. Children with
secondary hypertension present as asymptomatic unless
the pressure is sustained or raising rapidly [18]. Clinical
manifestations of underlying diseases include such
things as failure to thrive and failure to grow [18].
Significant elevation of blood pressure can lead to head-
aches, dizziness, visual changes, nausea, epistasis, and
seizures [13].
Treatment
Once a definitive diagnosis of pre-hypertension or
hypertension has been established, a treatment regimen
must be outlined. As previously mentioned, increased
BMI is closely related to hypertension, so if the hyper-
tensive child is obese, a weight loss plan should be estab-
lished [23]. Weight loss plans can include increased
physical activity, diet modification, and behavioral ther-
apies [23].
If diet and lifestyle changes fail to resolve hypertension
after more than 6 months, this could be an indication
that additional pharmacologic treatment is needed [24].
Other indications for pharmacologic treatment in adoles-
cents include diabetes mellitus, chronic kidney disease,
and stage II hypertension [24]. The use of pharmacologic
treatment in pediatrics is controversial and should only be
used when diet and exercise were not successful. Primary
medications to consider for first line treatment are:
angiotensin-converting enzyme (ACE) inhibitor, calcium
channel blocker, angiotensin II receptor blocker (ARB),
diuretic, and beta blocker drug classes [24].
If a secondary pharmacologic therapy is needed, the
selection of this medication will need to be based on the
primary medication chosen due to medication interactions
and comorbidities [24].
Conclusion
Hypertension in children and adolescents is a rising
health concern that should be taken seriously and diag-
nosed early. With obesity on the rise, we can only con-
clude that the issue of prehypertension and hypertension
will increase as well. With the introduction of increased
physical activity and a well balanced diet, we are opti-
mistic that obesity and thus hypertension can be
treated without the need for additional pharmacologic
intervention.
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